Publication

Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma

Journal Paper/Review - Jun 1, 2018

Weyerbrock Astrid